Literature DB >> 22567520

Prenatal diagnosis of congenital mesenchymal hamartoma of liver: a case report.

Sreelakshmi Kodandapani1, Muralidhar V Pai, Vijay Kumar, Kanthilatha V Pai.   

Abstract

Hepatic mesenchymal hamartoma is a rare benign tumor. We present an unusual case of a fetal abdominal cyst, later diagnosed histopathologically to be mesenchymal hamartoma of liver. The organ of origin was indeterminate on both prenatal and postnatal ultrasounds. As there are no specific sonological findings, whenever a large multicystic fetal abdominal cyst is seen, mesenchymal hamartoma should be considered as a possibility.

Entities:  

Year:  2011        PMID: 22567520      PMCID: PMC3335557          DOI: 10.1155/2011/932583

Source DB:  PubMed          Journal:  Case Rep Obstet Gynecol        ISSN: 2090-6692


1. Introduction

Increase use of antenatal ultrasound has resulted in greater incidence of prenatal diagnosis of congenital malformations. Many anomalies which manifest in the third trimester are diagnosed, as serial growth of fetus is monitored by ultrasound. Fetal abdominal cyst with normal kidneys and liquor in the third trimester is probably ovarian cyst, mesenteric cyst, or rarely mesenchymal hamartoma of liver as reported in this case. Mesenchymal hamartoma is a cystic benign tumor, but rapid growth to enormous size can lead to fetal hydrops and demise. Case report with management and review of the literature of congenital mesenchymal hamartoma of liver is presented.

2. Case Report

A 25-year-old primigravida was referred to us at 38 weeks for management of cardiac disease complicating pregnancy. Incidentally, during antenatal ultrasound, an intra-abdominal anechoic cyst, just above the level of kidneys, measuring 7 × 8 cm was noted (Figure 1). Bladder was visualized separately. Placenta was situated in the upper segment and amniotic fluid index was normal. Intra-abdominal organs, heart, and diaphragm were not displaced. Estimated fetal weight was 2.3 kg suggesting mild IUGR. Provisional diagnosis of either mesenteric, ovarian, or duplication cyst was considered. She had mitral valve prolapse with NYHA class I. Since cyst was neither compressing other organs nor distending abdomen, vaginal delivery was planned. However, cesarean delivery was done for fetal distress. A female baby of 2.15 kg, with APGAR 9 and 10 at 1 and 5 minutes, respectively, was delivered. Postnatal examination of the baby revealed a palpable cystic mass of 10 × 8 cm in the right hypochondrium. No other congenital abnormalities were noted. Baby tolerated feeds well. Ultrasound was suggestive of an anechoic cyst in close relation to the left lobe of liver. Conservative management was advised by pediatric surgeon. Baby was on regular followup.
Figure 1

Prenatal ultrasound picture showing intra-abdominal cyst measuring 8 × 8 cm.

However, laparotomy was performed at 2 months for persistence of cyst. Liver function, renal function tests, and electrolytes were preoperatively normal. At laparotomy, a cystic lesion arising from 5th segment of liver was noted and the same was excised (Figure 2). Histopathology revealed that the cyst was devoid of lining epithelium and was lined by hyalinized fibrous tissue suggestive of mesenchymal hamartoma of liver (Figure 3).
Figure 2

Intraoperative picture showing cyst arising from liver.

Figure 3

Histopathological image with fluid-filled lakes and devoid of epithelium.

Postoperative period was uneventful. After 2 months of surgery, a small cystic lesion (4 × 1 cm) was seen arising from the inferior part of right lobe of liver. It was decided to followup, the cyst. At the end of 2 months of postoperative follow up the cystic lesion reduced in size to 5 mm and baby was asymptomatic with good catch up growth.

3. Discussion

Hepatic tumors are rare and comprise of 5% of the total neoplasms in fetal and neonatal period [7]. After hemangiomas, mesenchymal hamartomas are the second most common hepatic tumours in childhood [8]. Hepatic mesenchymal hamartoma is a benign tumor, defined as an excessive focal overgrowth of mature normal cells and stroma native to the liver. Hamartomas are devoid of lining epithelium with hemorrhage and necrosis. They are well circumscribed and are away from the biliary ducts. Liver architecture and function is well maintained. With the advent of high resolution ultrasound, these can be detected prenatally as intra-abdominal cysts of unknown origin. Typically, hamartomas of liver are not associated with any anomalies, but associations with congenital heart disease, gut malrotation, omphalocele, myelomeningocele, and biliary atresia have been reported [9]. Prognostic factors are period of gestation of presentation, tumor size, rate of growth, and associated anomalies. In the largest series by Isaacs Jr, 45 cases of mesenchymal tumors are reported over a period of 35 years (1970–2005) [10]. A total of 14 cases were antenatally diagnosed in this series and most common presentation was abdominal cyst with a mean gestational age of 35 weeks (15–40). While 64% underwent surgical resection, only 10 untreated survived. Most common cause of death was rapidly progressive tumor with respiratory distress. Overall survival was 64% in this series [10]. Slow growth and late onset presentation of cyst in our case was a favorable factor. Early onset of presentation, rapidly progressing tumor, and polyhydramnios compression of arteries are poor prognostic factors which were seen in cases reported by Dickinson et al., Tsao et al., and Laberge et al. [4-6] (Table 1). Thus, these patients should be on regular followup. Rapidly growing tumor may require antenatal aspiration of cyst as was performed in one of the cases reported by Tsao et al. [5].
Table 1

Congenital mesenchymal hamartoma of liver: presentation and management.

Author, year, number of cases (n)Gestational age (weeks)Presentation/mode of deliveryManagementPost-op course followupTumour size
Kamata et al. [1] 2003 n = 130Rapidly growing cyst with maternal hypertension, anemia, preterm labor. Cesarean deliverySurgical resection3-year followup: alive and healthy7 × 6 × 5 cm
Bartho et al. [2] 1992 n = 131Abdominal cyst. Cesarean deliveryHepato lobectomyNA7 × 4 cm
Tovbin et al. [3] 1997 n = 129Abdominal cyst. Vaginal deliverySurgical excision15th postnatal day10 × 8 cm
Dickinson et al. [4] 1999 n = 126Progressing abdominal mass fetal hydrops, fetal demise. Vaginal deliveryNilNil8 × 7 × 6 cm
Tsao et al. [5] 2002 n = 2Fetus 1: 35Fetus 1: rapidly growing mass, vaginal delivery. Fetus 2: rapidly progressing mass, fetal hydropsFetus 1: antenatalaspiration postnatal laparoscopic excision of cyst. Fetus 2: excision, neonatal deathFetus 1: two-week postoperative period was normalFetus 2: autopsy showed hamartoma umbilical vein compressionFetus 1: 9 × 6 cm Fetus 2: 13 × 13 × 7 cm weighed 635 g
Laberge et al. [6] 2005 n = 123Abdominal cyst polyhydramnios, fetal hydrops, fetal demiseNilPlacental villous hyperplasia

NA: not available.

Cesarean delivery is not per se indicated unless it is a big tumor anticipating abdominal dystocia as can be inferred from Table 1. Recurrence and malignant transformation is rarely observed, hence, warrants careful follow up [11]. Our case has been followedup for 6 months at the time of reporting and has appropriate growth and neurodevelopment.
  11 in total

Review 1.  Hepatic tumors in the pediatric age group: a distinctive clinicopathologic spectrum.

Authors:  L P Dehner
Journal:  Perspect Pediatr Pathol       Date:  1978

Review 2.  Malignant transformation of mesenchymal hamartoma of the liver: case report and review of the literature.

Authors:  T M Ramanujam; J C Ramesh; D W Goh; K T Wong; W A Ariffin; G Kumar; N A Taib
Journal:  J Pediatr Surg       Date:  1999-11       Impact factor: 2.545

Review 3.  Mesenchymal hamartoma of the liver: a systematic review.

Authors:  Mark D Stringer; Naved K Alizai
Journal:  J Pediatr Surg       Date:  2005-11       Impact factor: 2.545

Review 4.  Fetal mesenchymal hamartoma of the liver: report of a case.

Authors:  Shinkichi Kamata; Keisuke Nose; Toshio Sawai; Toshimichi Hasegawa; Seika Kuroda; Takashi Sasaki; Akira Okada; Masahiro Tawara
Journal:  J Pediatr Surg       Date:  2003-04       Impact factor: 2.545

5.  Mesenchymal hamartoma of the liver: report of 30 cases and review of the literature.

Authors:  J T Stocker; K G Ishak
Journal:  Pediatr Pathol       Date:  1983 Jul-Sep

6.  Fetal therapy for giant hepatic cysts.

Authors:  KuoJen Tsao; Shinjiro Hirose; Roman Sydorak; Ruth B Goldstein; Geoffrey A Machin; Craig T Albanese; Diana L Farmer
Journal:  J Pediatr Surg       Date:  2002-10       Impact factor: 2.545

7.  [Prenatally diagnosed mesenchymal hamartoma of the liver].

Authors:  S Bartho; H J Schulz; R Bollmann; U Specht
Journal:  Zentralbl Pathol       Date:  1992-04

8.  Prenatal diagnosis of hepatic mesenchymal hamartoma.

Authors:  J E Dickinson; S Knowles; J M Phillips
Journal:  Prenat Diagn       Date:  1999-01       Impact factor: 3.050

Review 9.  Large hepatic mesenchymal hamartoma leading to mid-trimester fetal demise.

Authors:  J-M Laberge; Y Patenaude; V Desilets; L Cartier; S Khalife; L Jutras; M-F Chen
Journal:  Fetal Diagn Ther       Date:  2005 Mar-Apr       Impact factor: 2.587

Review 10.  Fetal and neonatal hepatic tumors.

Authors:  Hart Isaacs
Journal:  J Pediatr Surg       Date:  2007-11       Impact factor: 2.545

View more
  3 in total

1.  Hepatic cystic mesenchymal hamartoma.

Authors:  Debraj Sen; Y S Gulati; Anusree Majumder; Saikat Bhattacharjee; Ritwik Chakrabarti
Journal:  Med J Armed Forces India       Date:  2014-11-06

Review 2.  Benign liver tumors in pediatric patients - Review with emphasis on imaging features.

Authors:  Liliana Chiorean; Xin-Wu Cui; Andrea Tannapfel; Doris Franke; Martin Stenzel; Wojciech Kosiak; Dagmar Schreiber-Dietrich; Jörg Jüngert; Jian-Min Chang; Christoph F Dietrich
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

3.  Spontaneous Subcapsular Hematoma of the Fetal Liver: A Case Report and Review of Literature.

Authors:  James E Maher; Brittany Van Beek; Randall T Kelly; Peter Hsu
Journal:  AJP Rep       Date:  2015-07-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.